• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HEHEHE 标记的亲和体分子可通过 IMAC 进行纯化,方便地用 [⁹⁹(m)Tc(CO)₃](+)进行标记,并表现出改善的生物分布,减少肝放射性积聚。

HEHEHE-tagged affibody molecule may be purified by IMAC, is conveniently labeled with [⁹⁹(m)Tc(CO)₃](+), and shows improved biodistribution with reduced hepatic radioactivity accumulation.

机构信息

Department of Medical Sciences, Uppsala University, Sweden.

出版信息

Bioconjug Chem. 2010 Nov 17;21(11):2013-22. doi: 10.1021/bc1002357. Epub 2010 Oct 22.

DOI:10.1021/bc1002357
PMID:20964447
Abstract

Affibody molecules are a class of small (ca. 7 kDa) robust scaffold proteins suitable for radionuclide molecular imaging of therapeutic targets in vivo. A hexahistidine tag at the N-terminus streamlines development of new imaging probes by enabling facile purification using immobilized metal ion affinity chromatography (IMAC), as well as convenient ⁹⁹(m)Tc(CO)₃-labeling. However, previous studies in mice have demonstrated that Affibody molecules labeled by this method yield higher liver accumulation of radioactivity, compared to the same tracer lacking the hexahistidine tag and labeled by an alternative method. Two variants of the HER2-binding Affibody molecule Z(HER)₂(:)₃₄₂ were made in an attempt to create a tagged tracer that could be purified by immobilized metal affinity chromatography, yet would not result in anomalous hepatic radioactivity accumulation following labeling with ⁹⁹(m)Tc(CO)₃. In one construct, the hexahistidine tag was moved to the C-terminus. In the other construct, every second histidine residue in the hexahistidine tag was replaced by the more hydrophilic glutamate, resulting in a HEHEHE-tag. Both variants, denoted Z(HER)₂(:)₃₄₂-H₆ and (HE)₃-Z(HER)₂(:)₃₄₂, respectively, could be efficiently purified using IMAC and stably labeled with ⁹⁹(m)Tc(CO)₃ and were subsequently compared with the parental H₆-Z(HER)₂(:)₃₄₂ having an N-terminal hexahistidine tag. All three variants were demonstrated to specifically bind to HER2-expressing cells in vitro. The hepatic accumulation of radioactivity in a murine model was 2-fold lower with ⁹⁹(m)Tc(CO)₃-Z(HER2:342)-H₆ compared to ⁹⁹(m)Tc(CO)₃-H₆-Z(HER)₂(:)₃₄₂, and more than 10-fold lower with ⁹⁹(m)Tc(CO)₃-(HE)₃-Z(HER)₂(:)₃₄₂. These differences translated into appreciably superior tumor-to-liver ratio for ⁹⁹(m)Tc(CO)₃-(HE)₃-Z(HER)₂(:)₃₄₂ compared to the alternative conjugates. This information might be useful for development of other scaffold-based molecular imaging probes.

摘要

亲和体分子是一类小型(约 7 kDa)的刚性支架蛋白,适用于体内治疗靶点的放射性核素分子成像。N 端的六组氨酸标签通过使新的成像探针易于使用固定化金属离子亲和层析(IMAC)进行纯化,以及方便的 ⁹⁹(m)Tc(CO)₃标记,简化了其开发。然而,以前在小鼠中的研究表明,与缺乏六组氨酸标签且通过替代方法标记的相同示踪剂相比,用该方法标记的亲和体分子在肝脏中积累放射性更高。为了尝试创建一种可以通过固定金属亲和层析进行纯化的标记示踪剂,同时又不会导致用 ⁹⁹(m)Tc(CO)₃标记后肝脏放射性异常积聚,我们构建了两种 HER2 结合亲和体分子 Z(HER)₂(:)₃₄₂ 的变体。在一种构建体中,六组氨酸标签被移动到 C 端。在另一种构建体中,六组氨酸标签中的每两个组氨酸残基被更亲水的谷氨酸取代,形成 HEHEHE 标签。这两种变体分别表示为 Z(HER)₂(:)₃₄₂-H₆和(HE)₃-Z(HER)₂(:)₃₄₂,都可以通过 IMAC 进行有效纯化,并与具有 N 端六组氨酸标签的亲本 H₆-Z(HER)₂(:)₃₄₂稳定标记,随后与体外表达 HER2 的细胞进行比较。在小鼠模型中,与 ⁹⁹(m)Tc(CO)₃-H₆-Z(HER)₂(:)₃₄₂相比,⁹⁹(m)Tc(CO)₃-Z(HER2:342)-H₆的放射性在肝脏中的积累降低了 2 倍,而与 ⁹⁹(m)Tc(CO)₃-(HE)₃-Z(HER)₂(:)₃₄₂相比,降低了 10 倍以上。这些差异转化为 ⁹⁹(m)Tc(CO)₃-(HE)₃-Z(HER)₂(:)₃₄₂与其他缀合物相比,肿瘤与肝脏的比值明显更高。这些信息可能对其他支架基分子成像探针的开发有用。

相似文献

1
HEHEHE-tagged affibody molecule may be purified by IMAC, is conveniently labeled with [⁹⁹(m)Tc(CO)₃](+), and shows improved biodistribution with reduced hepatic radioactivity accumulation.HEHEHE 标记的亲和体分子可通过 IMAC 进行纯化,方便地用 [⁹⁹(m)Tc(CO)₃](+)进行标记,并表现出改善的生物分布,减少肝放射性积聚。
Bioconjug Chem. 2010 Nov 17;21(11):2013-22. doi: 10.1021/bc1002357. Epub 2010 Oct 22.
2
Use of a HEHEHE purification tag instead of a hexahistidine tag improves biodistribution of affibody molecules site-specifically labeled with (99m)Tc, (111)In, and (125)I.使用 HEHEHE 纯化标签代替六组氨酸标签可特异性改善(99m)Tc、(111)In 和(125)I 标记的亲和体分子的生物分布。
J Med Chem. 2011 Jun 9;54(11):3817-26. doi: 10.1021/jm200065e. Epub 2011 May 12.
3
Evaluation of a HER2-targeting affibody molecule combining an N-terminal HEHEHE-tag with a GGGC chelator for 99mTc-labelling at the C terminus.评估一种将N端HEHEHE标签与GGGC螯合剂相结合的HER2靶向亲和体分子,用于在C端进行99mTc标记。
Tumour Biol. 2012 Jun;33(3):641-51. doi: 10.1007/s13277-011-0305-z. Epub 2012 Jan 17.
4
HAHAHA, HEHEHE, HIHIHI, or HKHKHK: influence of position and composition of histidine containing tags on biodistribution of [(99m)Tc(CO)3](+)-labeled affibody molecules.哈哈哈,嘿嘿嘿,嘻嘻嘻,或 HKHKHK:组氨酸标签位置和组成对[(99m)Tc(CO)3](+)标记亲和体分子生物分布的影响。
J Med Chem. 2013 Jun 27;56(12):4966-74. doi: 10.1021/jm400218y. Epub 2013 Jun 14.
5
(99m)Tc-maEEE-Z(HER2:342), an Affibody molecule-based tracer for the detection of HER2 expression in malignant tumors.(99m)Tc-maEEE-Z(HER2:342),一种基于亲和体分子的示踪剂,用于检测恶性肿瘤中的HER2表达。
Bioconjug Chem. 2007 Nov-Dec;18(6):1956-64. doi: 10.1021/bc7002617. Epub 2007 Oct 19.
6
Effects of lysine-containing mercaptoacetyl-based chelators on the biodistribution of 99mTc-labeled anti-HER2 Affibody molecules.含赖氨酸的巯基乙酰基螯合剂对99mTc标记的抗HER2亲和体分子生物分布的影响。
Bioconjug Chem. 2008 Dec;19(12):2568-76. doi: 10.1021/bc800244b.
7
In/I/Tc-Labeled N-terminus tri-(histidine-glutamate) (HE)-tagged and N- or C-terminus hexahistidine (H6)-tagged anti-epidermal growth factor receptor Affibody Z-C铟-111/锝-99m标记的N端三(组氨酸-谷氨酸)(HE)标签以及N端或C端六组氨酸(H6)标签的抗表皮生长因子受体亲合体Z-C
8
Evaluation of a maleimido derivative of NOTA for site-specific labeling of affibody molecules.评价 NOTA 的马来酰亚胺衍生物用于亲和体分子的定点标记。
Bioconjug Chem. 2011 May 18;22(5):894-902. doi: 10.1021/bc100470x. Epub 2011 Apr 12.
9
Targeting of HER2-expressing tumors with a site-specifically 99mTc-labeled recombinant affibody molecule, ZHER2:2395, with C-terminally engineered cysteine.用一种位点特异性99mTc标记的重组亲和体分子ZHER2:2395靶向HER2表达肿瘤,该亲和体分子C端经工程改造含有半胱氨酸。
J Nucl Med. 2009 May;50(5):781-9. doi: 10.2967/jnumed.108.056929. Epub 2009 Apr 16.
10
On the selection of a tracer for PET imaging of HER2-expressing tumors: direct comparison of a 124I-labeled affibody molecule and trastuzumab in a murine xenograft model.关于用于HER2表达肿瘤PET成像的示踪剂选择:在小鼠异种移植模型中对124I标记的亲和体分子与曲妥珠单抗的直接比较。
J Nucl Med. 2009 Mar;50(3):417-25. doi: 10.2967/jnumed.108.057919. Epub 2009 Feb 17.

引用本文的文献

1
Affibody-based molecular probe Tc-(HE)Z for non-invasive HER2 detection in ovarian and breast cancer xenografts.基于亲和体的分子探针Tc-(HE)Z用于卵巢癌和乳腺癌异种移植瘤中HER2的无创检测
Open Med (Wars). 2024 Sep 3;19(1):20241027. doi: 10.1515/med-2024-1027. eCollection 2024.
2
Direct In Vivo Comparison of Tc-Labeled Scaffold Proteins, DARPin G3 and ADAPT6, for Visualization of HER2 Expression and Monitoring of Early Response for Trastuzumab Therapy.直接体内比较 Tc 标记的支架蛋白、DARPin G3 和 ADAPT6,用于可视化 HER2 表达和监测曲妥珠单抗治疗的早期反应。
Int J Mol Sci. 2022 Dec 2;23(23):15181. doi: 10.3390/ijms232315181.
3
Comparative Preclinical Evaluation of Peptide-Based Chelators for the Labeling of DARPin G3 with Tc for Radionuclide Imaging of HER2 Expression in Cancer.
用于 DARPin G3 的 Tc 标记的基于肽的螯合剂的比较临床前评价用于癌症中 HER2 表达的放射性核素成像。
Int J Mol Sci. 2022 Nov 3;23(21):13443. doi: 10.3390/ijms232113443.
4
The production of the first functional antibody mimetic in higher plants: the chloroplast makes the DARPin G3 for HER2 imaging in oncology.在高等植物中生产首个功能性抗体模拟物:叶绿体为癌症中的 HER2 成像生成 DARPin G3。
Biol Res. 2022 Oct 23;55(1):32. doi: 10.1186/s40659-022-00400-7.
5
Targeting Tumor Cells Overexpressing the Human Epidermal Growth Factor Receptor 3 with Potent Drug Conjugates Based on Affibody Molecules.基于亲和体分子的强效药物偶联物靶向过表达人表皮生长因子受体3的肿瘤细胞。
Biomedicines. 2022 May 31;10(6):1293. doi: 10.3390/biomedicines10061293.
6
Targeting HER2-positive gastric cancer with a novel F-labeled Z probe.用新型F标记的Z探针靶向HER2阳性胃癌。
RSC Adv. 2019 Apr 8;9(19):10990-10998. doi: 10.1039/c8ra10271f. eCollection 2019 Apr 3.
7
Effect of Inter-Domain Linker Composition on Biodistribution of ABD-Fused Affibody-Drug Conjugates Targeting HER2.结构域间连接子组成对靶向HER2的ABD融合亲和体-药物偶联物生物分布的影响
Pharmaceutics. 2022 Feb 26;14(3):522. doi: 10.3390/pharmaceutics14030522.
8
Comparative Preclinical Evaluation of HER2-Targeting ABD-Fused Affibody Molecules Lu-ABY-271 and Lu-ABY-027: Impact of DOTA Position on ABD Domain.HER2靶向的ABD融合亲和体分子Lu-ABY-271和Lu-ABY-027的临床前比较评估:DOTA位置对ABD结构域的影响
Pharmaceutics. 2021 Jun 7;13(6):839. doi: 10.3390/pharmaceutics13060839.
9
Optimal His-Tag Design for Efficient [Tc(CO)] and [Re(CO)] Labeling of Proteins for Molecular Imaging and Radionuclide Therapy by Analysis of Peptide Arrays.通过肽阵列分析优化 His-Tag 设计,以实现用于分子成像和放射性核素治疗的 [Tc(CO)] 和 [Re(CO)] 标记蛋白的高效性。
Bioconjug Chem. 2021 Jul 21;32(7):1242-1254. doi: 10.1021/acs.bioconjchem.0c00561. Epub 2020 Nov 26.
10
Increasing thermal stability and improving biodistribution of VEGFR2-binding affibody molecules by a combination of in silico and directed evolution approaches.通过计算模拟和定向进化方法的结合,提高 VEGFR2 结合亲和体分子的热稳定性和改善其生物分布。
Sci Rep. 2020 Oct 23;10(1):18148. doi: 10.1038/s41598-020-74560-5.